Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets
- PMID: 33340034
- PMCID: PMC7890948
- DOI: 10.1038/s41564-020-00841-4
Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets
Erratum in
-
Author Correction: Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets.Nat Microbiol. 2021 Mar;6(3):413. doi: 10.1038/s41564-021-00867-2. Nat Microbiol. 2021. PMID: 33462437 Free PMC article. No abstract available.
Abstract
Non-human primate models will expedite therapeutics and vaccines for coronavirus disease 2019 (COVID-19) to clinical trials. Here, we compare acute severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in young and old rhesus macaques, baboons and old marmosets. Macaques had clinical signs of viral infection, mild to moderate pneumonitis and extra-pulmonary pathologies, and both age groups recovered in two weeks. Baboons had prolonged viral RNA shedding and substantially more lung inflammation compared with macaques. Inflammation in bronchoalveolar lavage was increased in old versus young baboons. Using techniques including computed tomography imaging, immunophenotyping, and alveolar/peripheral cytokine response and immunohistochemical analyses, we delineated cellular immune responses to SARS-CoV-2 infection in macaque and baboon lungs, including innate and adaptive immune cells and a prominent type-I interferon response. Macaques developed T-cell memory phenotypes/responses and bystander cytokine production. Old macaques had lower titres of SARS-CoV-2-specific IgG antibody levels compared with young macaques. Acute respiratory distress in macaques and baboons recapitulates the progression of COVID-19 in humans, making them suitable as models to test vaccines and therapies.
Figures
















Comment in
-
More monkey models for studying COVID-19.Lab Anim (NY). 2021 Feb;50(2):44. doi: 10.1038/s41684-021-00717-y. Lab Anim (NY). 2021. PMID: 33505014 No abstract available.
Similar articles
-
Delayed severe cytokine storm and immune cell infiltration in SARS-CoV-2-infected aged Chinese rhesus macaques.Zool Res. 2020 Sep 18;41(5):503-516. doi: 10.24272/j.issn.2095-8137.2020.202. Zool Res. 2020. PMID: 32772513 Free PMC article.
-
Recovery from Acute SARS-CoV-2 Infection and Development of Anamnestic Immune Responses in T Cell-Depleted Rhesus Macaques.mBio. 2021 Aug 31;12(4):e0150321. doi: 10.1128/mBio.01503-21. Epub 2021 Jul 27. mBio. 2021. PMID: 34311582 Free PMC article.
-
Age-related differences in immune dynamics during SARS-CoV-2 infection in rhesus macaques.Life Sci Alliance. 2022 Jan 17;5(4):e202101314. doi: 10.26508/lsa.202101314. Print 2022 Apr. Life Sci Alliance. 2022. PMID: 35039442 Free PMC article.
-
Mucosal immunity to severe acute respiratory syndrome coronavirus 2 infection.Curr Opin Infect Dis. 2021 Jun 1;34(3):181-186. doi: 10.1097/QCO.0000000000000724. Curr Opin Infect Dis. 2021. PMID: 33899752 Review.
-
Endothelial cell, myeloid, and adaptive immune responses in SARS-CoV-2 infection.FASEB J. 2021 May;35(5):e21577. doi: 10.1096/fj.202100024R. FASEB J. 2021. PMID: 33831263 Free PMC article. Review.
Cited by
-
Whole Genome Analysis of SNV and Indel Polymorphism in Common Marmosets (Callithrix jacchus).Genes (Basel). 2023 Dec 7;14(12):2185. doi: 10.3390/genes14122185. Genes (Basel). 2023. PMID: 38137007 Free PMC article.
-
Bridging animal and clinical research during SARS-CoV-2 pandemic: A new-old challenge.EBioMedicine. 2021 Apr;66:103291. doi: 10.1016/j.ebiom.2021.103291. Epub 2021 Apr 1. EBioMedicine. 2021. PMID: 33813139 Free PMC article. Review.
-
Recovery from acute SARS-CoV-2 infection and development of anamnestic immune responses in T cell-depleted rhesus macaques.bioRxiv [Preprint]. 2021 Apr 4:2021.04.02.438262. doi: 10.1101/2021.04.02.438262. bioRxiv. 2021. Update in: mBio. 2021 Aug 31;12(4):e0150321. doi: 10.1128/mBio.01503-21. PMID: 33821272 Free PMC article. Updated. Preprint.
-
Animal models for studying coronavirus infections and developing antiviral agents and vaccines.Antiviral Res. 2022 Jul;203:105345. doi: 10.1016/j.antiviral.2022.105345. Epub 2022 May 21. Antiviral Res. 2022. PMID: 35605699 Free PMC article. Review.
-
Exposure modality influences viral kinetics but not respiratory outcome of COVID-19 in multiple nonhuman primate species.PLoS Pathog. 2022 Jul 5;18(7):e1010618. doi: 10.1371/journal.ppat.1010618. eCollection 2022 Jul. PLoS Pathog. 2022. PMID: 35789343 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
- T32 AG021890/AG/NIA NIH HHS/United States
- R01 AI134236/AI/NIAID NIH HHS/United States
- P51OD011133/U.S. Department of Health & Human Services | NIH | NIH Office of the Director (OD)/International
- R01AI134236/U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)/International
- P30 AG044271/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous